The Budget provides $10 million for a review in two years of an agreement that expires the year after. The Government is investing more in this review than it has in the Health Technology Assessment Review.
Budget reveals wholesaling arrangements are a future focus
March 25, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Weight loss medicines drive revenue sales growth for Sigma and Wesfarmers Health
August 28, 2026 - - BioPharma -
Patients Australia put healthcare’s quiet achievers in the spotlight
August 28, 2026 - - Latest News -
Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients
August 28, 2026 - - Latest News -
Mayne Pharma bets on women’s health and direct distribution after a difficult year
August 28, 2026 - - Latest News -
Cathy Freeman to headline 2026 Patient’s Choice Awards
August 27, 2026 - - Latest News -
Australian company secures Mitsubishi partnership to bring BioPQQ to market
August 26, 2026 - - Latest News -
Noxopharm pushes Sofra platform towards cancer proof of concept
August 26, 2026 - - Australian Biotech
